Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sequent Scientific LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:512529NSE Symbol: SEQUENTP/E(TTM):217.36
ISIN Demat:INE807F01027Div & Yield %:0EPS(TTM):0.74
Book Value(Rs):44.2953081Market Cap ( Cr.):4026.11Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 168.52222.69219.63265.46227.33166.26
Excise Duty0.000.000.000.000.000.00
Net Sales168.52222.69219.63265.46227.33166.26
Other Income 45.9828.2427.6419.9714.5613.96
Stock Adjustments -5.35-19.4219.7315.563.892.95
Total Income209.15231.51267.00300.99245.78183.17
EXPENDITURE :      
Raw Materials 102.54116.50128.39124.43116.9397.57
Power & Fuel Cost12.8913.9311.9612.7712.748.52
Employee Cost 30.0536.6627.3822.4217.1010.71
Other Manufacturing Expenses 26.2141.5452.5357.7350.5639.93
Selling and Administration Expenses 17.8619.4919.4020.279.988.36
Miscellaneous Expenses 6.541.520.4510.681.681.43
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure196.09229.63240.11248.29208.98166.52
Operating Profit13.061.8826.8952.7036.8016.64
Interest 4.362.511.612.685.043.22
Gross Profit8.70-0.6325.2850.0231.7613.42
Depreciation8.949.129.599.138.957.22
Profit Before Tax-0.24-9.7515.6940.8922.816.20
Tax0.46-0.570.376.093.18-0.05
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-1.32-3.090.522.69-1.71-1.33
Reported Net Profit0.62-6.0814.8032.1121.347.59
Extraordinary Items -1.690.000.00-0.750.000.00
Adjusted Net Profit2.31-6.0814.8032.8621.347.59
Adjst. below Net Profit 2.650.090.0743.38-1.300.32
P & L Balance brought forward38.7630.5628.03-47.47-62.65-70.55
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.00-14.1912.340.004.860.00
P & L Balance carried down42.0338.7630.5628.03-47.47-62.65
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.0025.000.0010.00
Earnings Per Share-Unit Curr0.02-0.240.601.290.860.31
Earnings Per Share(Adj)-Unit Curr0.02-0.240.601.290.860.31
Book Value-Unit Curr43.5942.4341.5541.4535.6837.18